Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00362635
Recruitment Status : Completed
First Posted : August 10, 2006
Last Update Posted : July 26, 2012
Sponsor:
Information provided by:
Bukwang Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2011
Study Completion Date : No date given